Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 70518-4776

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 70518-4776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of esomeprazole magnesium, showing the molecular arrangement including the magnesium ion complexed with esomeprazole molecules and associated water molecules (Mg2+ with 3 H2O).*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph displaying the percentage of patients maintaining a treatment effect over six months. It compares four groups: Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 20 mg, and 10 mg doses, and a placebo group. The y-axis represents percent maintained, and the x-axis represents months from 0 to 6.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph depicting the percentage of participants maintaining a condition over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The Y-axis shows percent maintained, and the X-axis shows months, with Esomeprazole Magnesium groups showing higher maintenance rates than placebo across the timeline.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
This line graph shows the percent of patients symptom-free over a 28-day diary period for three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, Esomeprazole Magnesium Delayed-Release Capsules 20 mg, and Placebo. The y-axis represents the percent symptom-free, and the x-axis represents diary days from 0 to 28.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
Line graph showing the percentage of patients symptom-free over 28 days (Diary Day) for Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The graph compares patient outcomes across the three groups over the study period.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Esomeprazole Magnesium 20 mg delayed-release capsules packaging label showing a quantity of 90 capsules. The label includes the NDC number 70518-4776-00 and indicates the product is repackaged by RemedyRepack Inc., Indiana, PA. The label also provides storage instructions and manufacturer details for Somerset Therapeutics LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.